SCHEMBL17786579

SCHEMBL17786579

Cn1c(Cl)nc2cc(Nc3ccccc3C(=O)O)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ TTR P02766 2/20 0.49
▸ FTO Q9C0B1 8/20 0.47
▸ TAS2R14 Q9NYV8 3/20 0.46
▸ FABP4 P15090 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ RECQL P46063 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ PBRM1 Q86U86 1/20 0.44
▸ PTGS1 P23219 2/20 0.43
▸ PTGS2 P35354 2/20 0.43
▸ AKR1C3 P42330 2/20 0.43
▸ AKR1C2 P52895 2/20 0.43
▸ AKR1B10 O60218 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786597 0.91 TTR (0.49) TTRFTOTAS2R14FABP4MEN1
SCHEMBL14870530 0.78 KDM4E (0.56) POLBMAPTTTRTAS2R14FABP4
SCHEMBL4327511 0.76 NPC1 (0.54) NPC1MAPTRAB9ATTRTAS2R14
SCHEMBL17786361 0.73 TTR (0.51) TTRFTOTAS2R14FABP4MEN1
SCHEMBL10385663 0.72 MEN1 (0.72) NPC1MAPTRAB9ATTRFTO
SCHEMBL11611911 0.71 TTR (0.67) NPC1MAPTRAB9ATTRFTO
SCHEMBL1649780 0.71 TTR (0.62) NPC1MAPTRAB9ATTRFTO
SCHEMBL18109767 0.71 FABP4 (0.85) MAPTTTRTAS2R14FABP4MEN1
SCHEMBL17786362 0.71 TTR (0.51) POLBTTRFTOTAS2R14FABP4
SCHEMBL10144151 0.70 FABP4 (0.62) NPC1MAPTTTRFTOTAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016083490-A1 COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES REMYND NV (BE) 2016-06-02 — — WO disclosed
Send feedback